Kala Pharmaceuticals's market cap is currently $41.66M. The company's EPS TTM is $-12.472; its P/E ratio is ―; Kala Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-2.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 3.89M	$ 11.24M	$ 6.36M	$ 6.07M
Gross Profit	$ -303.00K	$ 1.33M	$ 7.14M	$ 3.19M	$ 4.07M
Operating Income	$ -39.15M	$ -81.36M	$ -109.43M	$ -96.23M	$ -88.22M
EBITDA	$ -36.08M	$ -36.70M	$ -131.96M	$ -92.90M	$ -83.25M
Net Income	$ -42.20M	$ -223.00K	$ -152.30M	$ -112.00M	$ -101.98M
Balance Sheet
Cash & Short-Term Investments	$ 50.90M	$ 70.50M	$ 92.14M	$ 153.54M	$ 85.45M
Total Assets	$ 55.95M	$ 86.82M	$ 139.43M	$ 221.61M	$ 154.32M
Total Debt	$ 36.32M	$ 42.95M	$ 80.19M	$ 100.92M	$ 101.18M
Net Debt	$ -14.57M	$ -27.55M	$ -11.95M	$ 23.65M	$ 15.73M
Total Liabilities	$ 48.45M	$ 67.85M	$ 122.62M	$ 121.61M	$ 124.63M
Stockholders' Equity	$ 7.50M	$ 18.97M	$ 16.80M	$ 100.00M	$ 29.69M
Cash Flow
Free Cash Flow	$ -28.54M	$ -79.22M	$ -109.12M	$ -92.64M	$ -94.06M
Operating Cash Flow	$ -27.93M	$ -78.91M	$ -108.23M	$ -90.69M	$ -92.72M
Investing Cash Flow	$ -429.00K	$ 62.72M	$ 70.80M	$ -78.21M	$ -1.33M
Financing Cash Flow	$ 8.51M	$ -7.94M	$ 42.55M	$ 160.63M	$ 8.98M

Currency in USD

Kala Pharmaceuticals Earnings and Revenue History

Income Statement >

Kala Pharmaceuticals Debt to Assets

Balance Sheet >

Kala Pharmaceuticals Cash Flow

Cash Flow >

Kala Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing